Company news

Natera, Inc. news in 2021

Natera, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Natera Presents Latest Signatera™ MRD Data in Breast Cancer at SABCS 2021

December 8, 2021

Natera Reports Third Quarter 2021 Financial Results

November 3, 2021

Natera Validates Prospera™ With Quantification in Multi-Site, Prospective Trifecta Study

November 2, 2021

Natera Announces Third Quarter 2021 Earnings Conference Call

October 27, 2021

Natera Expands Organ Health Business With Commercial Launch of the Prospera™ Lung Transplant Assessment Test

October 17, 2021

Natera Announces New Publication Validating Signatera® Velocity Metric to Improve Cancer Management

October 10, 2021

Natera Announces Completion of the Largest Prospective Validation Study of a Commercial Cell-Free DNA Test in Lung Transplantation

October 5, 2021

Natera Releases New Clinical Data at ESMO 2021 in Gastroesophageal Cancer and Uveal Melanoma

September 16, 2021

Natera Launches Prospera™ Kidney with Quantification to Further Improve Test Performance, Demonstrating Commitment to Innovation in Transplantation

September 8, 2021

Natera Announces the Validation and Launch of the Prospera™ Heart Transplant Assessment Test

August 30, 2021

Natera Reports Second Quarter 2021 Financial Results

August 4, 2021

Natera Announces Use of Signatera® as a Companion Diagnostic in GSK's Phase III ZEST Trial for Niraparib in Early-Stage Breast Cancer

August 3, 2021

Natera Announces Second Quarter 2021 Earnings Conference Call

July 28, 2021

Natera Reports Preliminary Second Quarter 2021 Results

July 18, 2021

Natera and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in China

June 23, 2021

Natera Awarded Advanced Diagnostic Laboratory Test (ADLT) Status for its Signatera® MRD Test From CMS

June 17, 2021

Natera Announces New Prospera™ Data at the ATC 2021 Virtual Connect Conference

June 3, 2021

Natera Reports First Quarter 2021 Financial Results

May 5, 2021

Natera Announces First Quarter 2021 Earnings Conference Call

April 28, 2021

Natera Implements First Wave of Panorama® AI Improvements With Immediate Impact on Patient Experience and COGS

April 6, 2021

Natera and Tesis Labs Announce Strategic Collaboration on Prenatal Genetic Testing

March 30, 2021

Natera Reports Fourth Quarter and Year 2020 Financial Results

February 24, 2021

Natera Announces Fourth Quarter and Fiscal 2020 Earnings Conference Call

February 17, 2021

Panorama® SMART Study Confirms Market-Leading Performance in Largest Prospective NIPT Trial to Date

February 2, 2021

Natera Files Patent Infringement Suit Against Inivata

January 19, 2021

Calls in 2021

Decks in 2021